Cargando…

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action

BACKGROUND: Malaria still has significant impacts on the world; particularly in Africa, South America and Asia where spread over several millions of people and is one of the major causes of death. When chloroquine diphosphate (CQDP) lost its efficiency as a first-line anti-malarial drug, this was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Maribel, Castro, William, Madamet, Marilyn, Amalvict, Rémy, Benoit, Nicolas, Pradines, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289335/ https://www.ncbi.nlm.nih.gov/pubmed/25470995 http://dx.doi.org/10.1186/1475-2875-13-471

Ejemplares similares

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
por: Foguim, Francis Tsombeng, et al.
Publicado: (2020)

The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates
por: Gendrot, Mathieu, et al.
Publicado: (2018)

Copper (I)-Chloroquine Complexes: Interactions with DNA and Ferriprotoporphyrin, Inhibition of β-Hematin Formation and Relation to Antimalarial Activity
por: Villarreal, Wilmer, et al.
Publicado: (2022)

Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs
por: Foguim, Francis Tsombeng, et al.
Publicado: (2019)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014
por: Boussaroque, Agathe, et al.
Publicado: (2016)

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
por: Pascual, Aurélie, et al.
Publicado: (2013)

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs
por: Pascual, Aurélie, et al.
Publicado: (2011)

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010)

Assessment of a Commercial Real-Time PCR Assay (Vitassay qPCR Malaria 5 Test) to Detect Human Malaria Infection in Travelers Returning to France
por: Madamet, Marylin, et al.
Publicado: (2022)

Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
por: Gaillard, Tiphaine, et al.
Publicado: (2018)

1H-1,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluation
por: Kumar, Kewal, et al.
Publicado: (2014)

Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria
por: Yeo, Seon-Ju, et al.
Publicado: (2017)

Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
por: Tam, Dao Ngoc Hien, et al.
Publicado: (2020)

Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016)

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015)

In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine
por: Sahu, Rajnish, et al.
Publicado: (2014)

Erratum to: Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016)

Anti-Malarial Measures in Travancore
por: Watson, Malcolm
Publicado: (1932)

The Future of Anti-Malarial Research
por: Senior-White, Ronald, et al.
Publicado: (1927)

Anti-Malarial Sanitation in India
Publicado: (1904)

Anti-Malarial Sanitation in India
por: Goodbody, C. M.
Publicado: (1904)

Punjab Anti-Malarial Campaign
Publicado: (1911)

Anti-Malarial Operations in India
por: Bose, P. N.
Publicado: (1941)

The Synthetic Anti-Malarial Compounds
Publicado: (1933)

Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations
por: Khalil, Insaf F, et al.
Publicado: (2011)

Comparative Assessment of the Sensitivity of Ten Commercial Rapid Diagnostic Test Kits for the Detection of Plasmodium
por: Gendrot, Mathieu, et al.
Publicado: (2022)

Malaria burden and anti-malarial drug efficacy in Owando, northern Congo
por: Singana, Brice P., et al.
Publicado: (2016)

In Vivo Anti-Malarial Activity of Heracleum persicum Fruit Extract, in Combination with Chloroquine against Chloroquine–Sensitive Strain of Plasmodium berghei
por: MAZHARI, Nahideh, et al.
Publicado: (2018)

Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Das, Rashmi Ranjan, et al.
Publicado: (2020)

Anti-malarial effect of gum arabic
por: Ballal, Adil, et al.
Publicado: (2011)

Biological evaluation of hydroxynaphthoquinones as anti-malarials
por: Schuck, Desiree C, et al.
Publicado: (2013)

Artemisinin anti-malarial drugs in China
por: Guo, Zongru
Publicado: (2016)

Fake anti-malarials: start with the facts
por: Kaur, Harparkash, et al.
Publicado: (2016)

The Value of Anti-Malarial Public Works
Publicado: (1906)

Anti-Malarial Measures, Ancient and Modern
por: Hamilton, H.
Publicado: (1905)

Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015
por: Diawara, Silman, et al.
Publicado: (2017)

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
por: Monatrakul, Preeyaporn, et al.
Publicado: (2010)

Nucleoside-lipid-based nanocarriers for methylene blue delivery: potential application as anti-malarial drug
por: Kowouvi, Koffi, et al.
Publicado: (2019)

Combating poor-quality anti-malarial medicines: a call to action
por: Bassat, Quique, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_65rt77e0jrnbo8pj0o91j60v3o